← Back to Search

mHealth App for Chronic Lower Back Pain

N/A

Waitlist Available

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up recorded daily for 7 days starting at enrollment and after the completion of each 28-day cycle

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether a new app can help improve quality of life and minimize symptoms in patients with chronic low back pain.

Who is the study for?

This trial is for adults over 18 with chronic low back pain lasting at least 6 months, who can make medical decisions and read English. They must own an iPhone compatible with Apple ResearchKit (iOS 8 or 9) and have internet access. Pregnant individuals, prisoners, those decisionally impaired, or with severe health issues limiting physical therapy participation are excluded.

What is being tested?

The trial is testing a mobile app called Stanford SpineKeeper designed to manage chronic lower back pain through personalized interventions. It uses the Apple ResearchKit platform to deliver a multidisciplinary approach aimed at improving quality of life for patients.

What are the potential side effects?

Since this intervention involves using a mobile health application rather than medication, traditional side effects are not expected. However, users may experience discomfort from increased activity if recommended by the app.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ recorded daily for 7 days starting at enrollment and after the completion of each 28-day cycle

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~recorded daily for 7 days starting at enrollment and after the completion of each 28-day cycle

This trial's timeline: 3 weeks for screening, Varies for treatment, and recorded daily for 7 days starting at enrollment and after the completion of each 28-day cycle for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in back range of motion

Change in daily steps

Change in pain score

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Patients can choose among or choose to be assigned to 2 tracks for management for their low back pain. The tracks include one focused on relaxation and symptom management, and another track on increasing activity. Each include educational material adapted from various sources from North America Spine Society (NASS), Center for Disease Control (CDC), National Institue of Health (NIH). Patients will stay in track for 28 days. After this, they may choose to remain in track and continue to perform maintenance activities or to engage in a different track.

Do I qualify?Apply below to find out